Showing results (581-590 of 2,487) with videos related to
Sort By:
Pageof 249
Expert Review of Vaccines|June 8, 2026
From burden to benefit: overcoming barriers to immunization in adults, with a focus on respiratory syncytial virusCláudia Vicente, Filipe Froes, Pier Luigi Lopalco, et al.Expert Review of Vaccines|January 11, 2021
Microneedle Systems for Vaccine Delivery: the story so farMd Kamal Hossain, Taksim Ahmed, Prabhat Bhusal, et al.Expert Review of Vaccines|July 21, 2021
Correlates of protection for meningococcal surface protein vaccines: lessons from the pastJamie Findlow, Jay Lucidarme, Muhamed-Kheir Taha, et al.Expert Review of Vaccines|June 13, 2026
Recent advances for the pharmaceutical production of highly attenuated poxviruses as viral vector platformsLinus G Weber, Michael W WolffExpert Review of Vaccines|August 30, 2013
A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn?Natalie G Martin, Matthew D SnapeExpert Review of Vaccines|January 31, 2014
Neisseria meningitidis B vaccines: recent advances and possible immunization policiesRoberto Gasparini, Daniela Amicizia, Alexander Domnich, et al.Expert Review of Vaccines|July 25, 2015
Multivalent meningococcal serogroup B vaccines: challenges in predicting protection and measuring effectivenessJan T Poolman, Peter RichmondExpert Review of Vaccines|February 24, 2015
Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigenKate L Seib, Maria Scarselli, Maurizio Comanducci, et al.Expert Review of Vaccines|June 14, 2026
Barriers to dengue vaccine uptake in international travelers: a mixed-methods studyRachata Charoenwisedsil, Saranath Lawpoolsri, Pinyo Rattanaumpawan, et al.Expert Review of Vaccines|July 1, 2026
Evaluating the socioeconomic value of adult respiratory immunization in Spain: a benefit-cost analysisMatthew Napier, Alejandra López-Ibánez de Aldecoa, Simon Brassel, et al.Pageof 249